Back
Immunovant Vs. Perspective Therapeutics Industry Stock Comparison
Buy
64
IMVT
Immunovant
Last Price:
34.06
Seasonality Move:
51.14%
Sell
48
CATX
Perspective Therapeutics
Last Price:
15.26
Seasonality Move:
-11.56%
Buy
64
Immunovant (IMVT)
is a Buy
Is Immunovant a Buy, Sell or Hold?
- The current Immunovant [IMVT] share price is $34.00. The Score for IMVT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- IMVT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $15.26. The Score for CATX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IMVT Stock Price Chart
What is Immunovant's stock price today?
-
The Immunovant share price today is $34.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMVT is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $15.26
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing slight buying pressure.
IMVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.92 | Buy |
| Relative Strength Index (14 RSI): | 67.79 | Buy |
| Chaikin Money Flow: | 549455 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.63 - 32.33) | Buy |
| Bollinger Bands (100): | (26.74 - 30.76) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.66 | Buy |
| Relative Strength Index (14 RSI): | 57.38 | Buy |
| Chaikin Money Flow: | 132968 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.6 - 15.46) | Buy |
| Bollinger Bands (100): | (11.57 - 16.07) | Buy |
IMVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.71 | Buy |
| 20-day SMA: | 31.22 | Buy |
| 50-day SMA: | 29.49 | Buy |
| 200-day SMA: | 32.72 | Buy |
| 8-day EMA: | 32.11 | Buy |
| 20-day EMA: | 31.18 | Buy |
| 50-day EMA: | 30.01 | Buy |
| 200-day EMA: | 29.86 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.22 | Buy |
| 20-day SMA: | 14.51 | Buy |
| 50-day SMA: | 13.03 | Buy |
| 200-day SMA: | 10.73 | Buy |
| 8-day EMA: | 15.15 | Buy |
| 20-day EMA: | 14.59 | Buy |
| 50-day EMA: | 13.72 | Buy |
| 200-day EMA: | 11.22 | Buy |
Immunovant Earnings Growth & IMVT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.08 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.65 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.
Immunovant Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||